Pharmaceutical policy · tiger.PHARMA
Evidence-based positioning at the intersection of medicines supply, market access, regulation and public communication.
Discuss your challenge →
Supply · market · resilience
Institutional supply, retail and public affairs require robust sourcing, regulatory clarity and positioning that links markets with patient supply.
We develop suitable models for hospital pharmacies, critical supply, retail concepts and stakeholder communication – factual, documented and executable.
For clinical, critical or international needs, alternatives, supply chains, qualification and evidence are managed as one process.
For manufacturers and retail, assortment, product requirements, distribution and B2B/B2C fulfilment are aligned.
Regulatory change, supply data and interests are turned into clear, defensible communication.
Services for
GDP.secure.QMS.smart — pharma expertise with a clear operational focus.
Expertise, data and delivery combined in a resilient solution.
Learn more →Expertise, data and delivery combined in a resilient solution.
Learn more →Expertise, data and delivery combined in a resilient solution.
Learn more →Expertise, data and delivery combined in a resilient solution.
Learn more →Contact
Contact in 10 seconds – clear, direct and in your language.